Fulcrum Therapeutics FULC
NASDAQ FULC
$3.70 -0.02 (-0.54%)
At close: Sep 29, 2026 · 4:00 PM EDT

Fulcrum Therapeutics (FULC) Receivables (2020 - 2024)

Updated

Fulcrum Therapeutics (FULC) posted Receivables of $2.1 million for Q4 2024, up 290.3% from $537,000 a year earlier.

Analysis

Fulcrum Therapeutics (FULC) Receivables (2020 - 2024) Analysis & Trends

Since Q4 2020, Fulcrum Therapeutics has reported Receivables for 6 quarters.

  • Annual Receivables shows a four-year compound annual growth rate of 40.8% (FY2020 to FY2024).
  • In prior years, Fulcrum Therapeutics' Receivables was $537,000 in FY2023 (+134.5%), $229,000 in FY2022 and $533,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Fulcrum Therapeutics 283.78 Mn 283.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 2.10 Mn
Dec 31, 2023 537,000.00
Sep 30, 2023 580,000.00
Jun 30, 2023 656,000.00
Dec 31, 2022 229,000.00
Dec 31, 2020 2,000.00
API Access

Fulcrum Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=FULC&period=max&api_key=YOUR_API_KEY